0001472595-18-000008.txt : 20180118 0001472595-18-000008.hdr.sgml : 20180118 20180118082233 ACCESSION NUMBER: 0001472595-18-000008 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171220 FILED AS OF DATE: 20180118 DATE AS OF CHANGE: 20180118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RICAURTE CHRISTOPHER SIMON CENTRAL INDEX KEY: 0001483685 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34746 FILM NUMBER: 18532968 MAIL ADDRESS: STREET 1: 5945 AIRPORT ROAD, SUITE 360 CITY: MISSISSAUGA STATE: A6 ZIP: L4V 1R9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: R1 RCM INC. CENTRAL INDEX KEY: 0001472595 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 020698101 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 401 NORTH MICHIGAN AVENUE STREET 2: SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-324-7820 MAIL ADDRESS: STREET 1: 401 NORTH MICHIGAN AVENUE STREET 2: SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Accretive Health, Inc. DATE OF NAME CHANGE: 20090918 4/A 1 wf-form4a_151628173956044.xml FORM 4/A X0306 4/A 2017-12-20 2017-12-21 0 0001472595 R1 RCM INC. RCM 0001483685 RICAURTE CHRISTOPHER SIMON C/O R1 RCM INC. 401 N. MICHIGAN AVENUE, SUITE 2700 CHICAGO IL 60611 0 1 0 0 Chief Financial Officer Performance-Based Restricted Stock Units 2017-12-20 4 A 0 276603 0 A Common Stock 276603.0 276603 D Represents a contingent right to receive the Issuer's common stock. The Reporting Person's original Form 4 inadvertently reported the maximum number of PBRSUs available to be achieved by the Reporting Person rather than the target number of PBRSUs actually awarded to the Reporting Person. Pursuant to the award agreement, the performance-based restricted stock units will be subject to both a time-based vesting condition and a performance-based vesting condition. The time-based vesting condition may be satisfied on the earlier of December 31, 2020 and a qualifying change of control (the "Performance Period"), subject to the Reporting Person not having ceased to perform services with the Issuer. The performance-based vesting condition may be satisfied based upon an average per share price of the Issuer's common stock as defined in the award agreement, measured at the end of the Performance Period. Vested shares will be delivered within two and one-half months following the end of the calendar year in which or with respect to which both the time-based and performance-based vesting conditions were satisfied. Amount represents 100% of the target award. The number of shares earned will be based upon the achievement of a performance-based vesting condition and will range from 0% to 200% of the target award. /s/ E. Terry Platis, Attorney-in-Fact 2018-01-18